FindTrial
Sign In

Study of the prevalence of 5HT2C genes polymorphisms among Egyptian patients with LifeLong premature ejaculation

Study of the prevalence of 5HT2C genes polymorphisms among Egyptian patients with LifeLong premature ejaculation - 5HT2C genes polymorphisms among patients with lifelong premature ejaculation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000023900
Enrollment
350
Registered
2016-09-02
Start date
2015-12-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patient with lifelong premature ejaculation

Interventions

250 diseased patients were enrolled in this study. 5 ml of blood was withdrawn from each patient to determine type og the gene polymorphism 100 controls patients were enrolled in this study. 5 ml of b

Sponsors

there is no sponsor because we developed the conception and study desgin by our selves. Also, we performed the statistical ananlysis by our selves
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: patients with lifelong premature ejaculation.

Exclusion criteria

Exclusion criteria: patients with erectile dysfunction of under pyschotic medications or suffer from major illnesses

Design outcomes

Primary

MeasureTime frame
Not yet identified as the study is still running—

Secondary

MeasureTime frame
Not yet identified as the study is still running—

Countries

Africa

Contacts

Public ContactSameh Fayek

Cairo University Andrology department

samehfayek@hotmail.com01227109309

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026